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Activation of paracrine growth factors by heparan
sulphate induced by glucocorticoid in A549 lung
carcinoma cells
N Yevdokimova* and RI Freshney
CRC Department of Medical Oncology, University of Glasgow, Garscube Estate, Bearsden, Glasgow G61 1BD, UK
Summary Alkaline phosphatase, a marker ofdifferentiation in the human alveolar adenocarcinoma cell line A549, is inducible by conditioned
medium from lung fibroblasts and by cytokines including oncostatin M and interleukin 6, but only in the presence of a glucocorticoid,
dexamethasone. Dexamethasone was shown to induce incorporation of [3H]glucosamine into three fractions of medium and cell trypsinate
from subconfluent A549 cells, eluting from DEAE ion-exchange chromatography. The first peak did not correspond to any of the unlabelled
glycosaminoglycans and was not characterized further. Induction was seen in two otherpeaks, corresponding to hyaluronic acid and heparan
sulphate. Ofthese, heparan sulphate, eluting as one well-defined peak (referred to as HS1) and anotherof loweractivity and less well defined
(HS2), was selected as the most likely to interact with growth factors and cytokines and was isolated from the eluate, concentrated and
desalted, and used in alkaline phosphatase induction experiments in place of dexamethasone. HS1 isolated from the medium (HS1m) of
subconfluent A549 cells was shown to replace dexamethasone in induction experiments with fibroblast-conditioned medium, oncostatin M
and interleukin 6. HS1 from the cell trypsinate and HS2 from the medium and trypsinate were inactive. As the activity of HS1m could be
abolished by heparinase and heparitinase but not by chondroitinase ABC, it was concluded that HS1m was a fraction of heparan sulphate
involved in the regulation of paracrine growth factoractivity in lung fibroblast-conditioned medium, and in the regulation of othergrowth factors
with potential roles in the paracrine control of cell differentiation.
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Differentiation ofthe mature phenotype in alveolartype II pneumo-
cytes is marked by the production of lipid pulmonary surfactant
(PS) and surfactant-associated proteins (Hawgood and Clements,
1990) and by an increase in alkaline phosphatase (AP) activity
(Edelson et al, 1988). Perinatal induction ofdifferentiation is medi-
ated by glucocorticoids and a paracrine factor, or factors, from
mesenchymally derived cells in the lung (Caniggia et al, 1991). In
vitro, the synthesis of pulmonary surfactant and alkaline phos-
phatase can be induced in A549, a cell line derived from a human
lung adenocarcinoma (Giard et al 1972), of reputedly type II cell
origin (Lieber et al, 1976), by conditioned medium from lung fibro-
blasts (CM) (Speirs et al, 1991). Whereas induction ofPS synthesis
by CM was enhanced by treating the fibroblasts with dexametha-
sone (DX) before and during the conditioning process, DX was not
required for the action of the CM on the A549 cells (Speirs et al,
1991). It is, however, required for the induction of alkaline phos-
phatase by CM and by several cytokines, such as oncostatin M
(OSM), interleukin 6 (IL-6), and interferons a and [3, andby insulin
(McCormick et al, 1995; McCormick and Freshney, 1996). OSM
has been found to have the greatest activity and potency of all
factors so far examined in the alkaline phosphatase assay, with a
peak response offivefold induction at 10 ng ml (McCormick and
Freshney, 1996) in the presence ofDX. It is inactive in the absence
of DX. We have also shown that OSM increases the expression of
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the surfactant protein B gene in NCI-H441 cells (another putative
type II or Clara cell-derived tumour cell line). Although combina-
tions ofcytokines, particularly with insulin, are active without DX,
their activity is still significantly enhanced by DX.
Preliminary experiments (J Paterson, J Sinclair and RI Freshney,
unpublished observations) showed that A549 cells, treated with
DX and then challenged with CM at intervals up to 5 days after
DX removal, showed induction of AP by CM in the absence of
DX. This suggested that the effect was stable and not due to
receptor up-regulation or modifications in intracellular signalling,
which would be expected to decay with a half-life of between a
few minutes and several hours. Stable effects that might influence
cytokine activity include modifications ofthe extracellular matrix
by synthesis of glycosaminoglyans (GAGs), particularly heparan
sulphate (HS), usually complexed with protein as proteoglycan
(Lopez-Casillas et al, 1993; de Wynter et al, 1993; Femig and
Gallagher, 1994). Previous work with cell lines from human
glioma showed that glucocorticoids cause a reduction in the
synthesis of hyaluronic acid and an increase in HS, particularly
cell-associated HS (Mackie et al, 1988). Previously preliminary
data had shown that A549 cells show enhanced 35SO42- incorpora-
tion in high molecular weight material released into the medium
following DX treatment (McLean, 1986), and this material shifted
to a lower molecular weight after pronase digestion, suggesting
that it may have been proteoglycan.
Paracrine growth factors and cytokines, such as IL-6 and inter-
feron-1 (IFN[B), capable ofinducing differentiation in tumourcells
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(Kohlhepp et al, 1987; Pfeffer and Eisenkfraft, 1991; Rose and
Bruce, 1991; Bruce et al, 1992; Oberg, 1992; Lotem and Sachs,
1995), constitute a potential modality for the treatment of malig-
nant tumours. A partially purified factor from DX-treated lung
fibroblasts was shown to inhibit growth of A549 cells grown as
xenografts in nude mice (Speirs et al, 1991). Separate studies have
demonstrated that paracrine factors are present in CM from fibro-
blasts (Post and Smith, 1984; Post et al, 1984; Speirs et al, 1991;
McCormick et al, 1995). Butpurification ofone ofthe main candi-
dates, fibrocyte-pneumocyte factor (FPF) (L Evans and RI
Freshney, unpublished observations), appears to result in loss of
activity, possibly as aresultofinstability ofthe purified factor. It is
possible that FPF from CM is only active ifco-purified with HS or
another stabilizing factor or if this is replaced by HS from the
target cells induced by glucocorticoid.
McCormick et al (1995) showed that pure, cloned, cytokines are
active singly, provided that DX is present, so there are some stable
active inducers of AP, many of which are reasonable candidates
for paracrine factors released by lung fibroblasts. As their activity
is dependent on DX however, it is important to determine the
nature ofthis dependence, on the one hand to understand better the
mechanism ofgrowth factor and cytokine action and, on the other,
to determine whether a purified activating factor could substitute
for DX, which may not always be appropriate for clinical treat-
ment, particularly ifit is prolonged and repeated.
We have analysed medium and trypsinate from A549 cells, after
treatment with DX, by anionic ion exchange chromatography, to
determine whether cell-associated or soluble factors are produced
under the influence of DX that could act as intermediates in the
response to DX and substitute for DX in the induction process. We
have shown that there is a marked stimulation of [3H]glucosamine
([3H]GLN) incorporation, particularly in the medium of subcon-
fluent A549 cells, and that a fraction eluted from DEAE in 0.35 M
sodium chloride, corresponding to an early-eluting fraction ofHS,
substitutes for DX in the induction of AP by CM and cytokines,
such as IL-6 and OSM. This fraction, which we have called HS1,
is present only after treatment of subconfluent cells with DX. An
adjacent fraction of HS, which we have called HS2, eluting at
0.4 M sodium chloride and corresponding to the majorpeak ofHS,
shows no activity. HS1 and HS2 from cell surface-associated
material, isolated following trypsinization, is also inactive. This
activity of HS1 is sensitive to both heparinase and heparitinase,
but not chondroitinase ABC and is probably, therefore, a species
ofheparan sulphate.
MATERIALS AND METHODS
Cell culture
A549 cells were obtained from the American Type Culture
Collection and were grown in a 50:50 mixture of Ham's FlO and
Dulbecco's modified Eagle medium (F1O:DMEM) (Life
Technologies) and supplemented with 10% fetal bovine serum
(Globepharm) (FIO:DMEMIOFB). They were propagated in
conventional plastic flasks (Bibby Sterilin or Nunc) and subcul-
tured weekly, seeding at 104 cells ml-' (2 x 103 cells cm-2), and
with one intermediate medium change. MOG-LF113 (LF113), a
line of normal fetal human lung fibroblasts derived in this labora-
tory were maintained as forA549 cells, but with a seeding concen-
tration of 2 x 104 ml-' (4 x 103 cells cm-2), and were not fed
between subcultures.
Preparation of fibroblast-conditioned medium (CM)
LF113 cells weregrown toconfluence, the serumreducedto 1%, and
the confluent monolayer was maintained for 8 days, at which time
the serum was removed and serum-free F1O:DMEM (SF) added for
a further 3 days (McCormick et al, 1995). This was collected and
designated CM. It was frozen and thawed at least once and filtered
through a0.22-gm filter (Millex GV, Millipore) before use.
Induction experiments
A549 cells were seeded into microtitration plates at 5 x 104 ml-',
5000 per well, in 100 gl of F1O:DMEMIOFB, and grown for 3
days. The medium was replaced with SF with or without 0.25 gM
dexamethasone and test compound(s). When CM was used it was
diluted to 50% in F1O:DMEM. Alkaline phosphatase activity was
determined after 24 or 72 h.
Alkaline phosphatase assay
Cells were grown in microtitration plates and, when ready for assay,
were washed in 0.85% sodiumchloride andfrozen and thawed three
times in 10 ,ul of0.85% sodium chloride. Alkaline phosphatase was
assayed by measuring the absorbance at 310 nm on aBiorad ELISA
plate reader ofp-nitrophenol (PNP) released of fromp-nitrophenyl
phosphate, using Sigma kit no. 104, following a 1-h incubation at
37°C. Activity is expressed as ,umol PNP released h-' 10-5 cells.
Duplicate cell counts were performed on replicate plates.
Preparation and fractionation of glycosaminoglycans
Labelling cells
A549 cells were seeded at 5 x 104 ml-l in 75-cm2 flasks in
FIO:DMEMlOFB and the medium replaced 24 h later with
F1O:DMEMlOFB with or without 0.25 gM DX. After a further
48 h, 7 ml of the same medium, containing 110 kBq (3 ,Ci) ml-1
D-[1-3H]glucosamine [99.9 GBq (2.7 Ci) mmol-'] was added and
the flasks incubated for a further 24 h. The medium from each
flask was then diluted with an equal volume of 0.1 M Tris-HCl,
pH 7.9, containing 1 mm calcium chloride and 3.0 mg ml-' pronase
(Sigma-Aldrich), and incubated for 18 h at 55°C. The reaction
was stopped by placing the tubes in a boiling bath for 2-3 min and
the solution frozen at-70°C until required.
To prepare cell-associated GAGs, 2.0 ml of0.05% trypsin (Life
Technologies) in 0.1 M Tris-HCl, 0.05 M sodium chloride, pH 7.9
(TBS), was added to the washed cell layer and incubated for
15 min. The cells were resuspended and collected into a universal
container, the flask washed with 2 ml of TBS containing 0.05%
soya bean trypsin inhibitor (Sigma-Aldrich) and added to the cell
suspension. This was centrifuged at 500 g for 5 min and the
pellet resuspended in 7 ml of TBS and a further 7 ml of pronase,
3.0 mg ml-' in TBS, and incubated for 18 h at 55°C. The reaction
was stopped by placing the tubes in a boiling bath for 2-3 min and
the solution frozen at-70°C until required.
Chromatography
The pronase digest was thawed, concentrated tenfold on a
Centriprep-3 (Whatman), diluted 1:10 with initial buffer (20 mM
Tris-HCl, pH 8.4), loaded on to a DEAE Memsep filter on a
ConSep intermediate pressure chromatography system (Perceptive
Biosystems) and eluted with a stepped 0-0.6 M sodium chloride
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Table 1 Induction of alkaline phosphatase in A549 cells by fibroblast-conditioned medium and dexamethasone
,umol PNP P-value Cells per P-value
h-1 10- cells well 10-5
Control 15.16 ± 1.89a 0.98 ± 0.31
0.25 gM DX 54.51 ± 9.38 0.0014 vs control 0.83 ± 0.20 0.60
CM 19.89 ± 2.74 0.18 vs control 1.01 ± 0.15 0.91
CM + 0.25 gM DX 95.96 ± 10.46 < 1 x 10-4 vs CM; 1.07 ± 0.18 0.74 vs control
0.12vs DX 0.80vsCM
0.39 vs DX
aStandard error of the means of seven experiments.
Table 2 Effect of DX on integrated counts from P3a from medium and
trypsinate of subconfluent cells
Source No DX With DX Fold increase
Medium 8105a 299 549 37.0
Trypsinate 1896 4616 2.4
Medium-trypsinate ratio 4.3 64.9
ad.p.m. per 106 cells.
gradient (Juricova and Deyl, 1975) (see dotted line in Figure 1).
Each fraction (1 ml) was diluted with 9.0 ml of scintillant and
counted on a Packard Tricarb 1600 TR scintillation spectrometer.
Commercially available GAGs (Sigma; hyaluronic acid
(H0902) from bovine trachea, heparan sulphate (H7641) from
bovine intestinal mucosa and chondroitin sulphate A (C8529) from
bovine trachea) were run on the ConSep system under identical
conditions and the concentration of GAGs in each fraction esti-
mated by the carbazole assay (Bitter and Muir, 1962). These data
are presented in Figure IA, in which HA is hyaluronic acid, HS is
heparan sulphate and CS is chondroitin sulphate.
Isolation offractions
Fractions (usually no. 23 and no. 24, but determined by radio-
activity profile; see Figure 1) were pooled to give HS1 and no. 26,
no. 27 and no. 28 to give HS2. These were concentrated tenfold on
a prewashed Centriprep-3, diluted tenfold in F1O:DMEM and ster-
ilized by filtration on a Millex GV filter (Millipore). The concen-
tration of GAGs was determined by the carbazole assay and
adjusted to the required amount. As HS1 lost a third ofits activity
when stored at -80°C and two-thirds when stored at -20°C, it was
used immediately after preparation.
Statistical analysis
Data are presented as the means ± standard error of the mean. P-
values were determined by the Student's t-test.
RESULTS
Requirement for DX for AP induction
Microtitration plate cultures ofA549 cells were exposed to CM in
the presence and absence of 0.25 JIM DX and to DX alone. DX
alone induced AP as previously reported (McCormick et al, 1995),
with a mean ratio offourtimes the serum-free control (s.e.m. 0.92,
P = 0.0014), CM alone gave slight induction in some experiments,
although this was not significant overall (P = 0.18), but CM in the
presence of DX gave a twofold induction of AP activity over DX
alone (P = 0.12) and sixfold over CM alone (P < 1 x 10-4) (Table
1). Cell counts showed a slight (average 20%) cytostatic effect of
DX, but this was not significant when analysed over the seven
experiments.
Effect of DX on incorporation of [3H]GLN incorporation
Flask cultures were labelled with [3H1GLN for 24 h after 3 days'
exposure to 0.25 gM DX during the exponential, early plateau and
late plateau phase of the growth cycle, and the GAGs in the
medium and trypsinate analysed as described in Materials and
methods. The elution profile of unlabelled GAGs (Sigma) are
shown with the salt gradient used in Figure IA.
Medium from subconfluent cells
There was a marked stimulation of incorporation of [3H]GLN
following exposure to DX (Figure iB). The largest peak (P1),
eluting at 0.15 M sodium chloride, did not correspond to any ofthe
unlabelled GAGs run under identical conditions, and may have
been non-GAG-related oligosaccharides or degraded GAGs. The
second peak (P2) eluted at 0.25 M sodium chloride and corre-
sponded to the position ofhyaluronic acid. The thirdpeak (P3) was
heterogeneous, with a sharp peak eluting at 0.35 M sodium
chloride (P3a) and a shoulder (P3b), eluting over the range from
0.36 to 0.4 M sodium chloride. P3 corresponded to the position of
the unlabelled heparan sulphate, the bulk of which eluted at 0.4 M
sodium chloride. Only relatively minor incorporation eluted in the
region of chondroitin sulphate (P4), which would also coincide
with dermatan sulphate, which elutes at approximately the same
salt concentration.
Medium from confluent (earlyplateauphase) cells
Although there was still stimulation of [3H]GLN uptake into P3a in
the presence ofDX, this was considerably reduced to about 10-20%
relative to 20-fold stimulation in subconfluent cells (Figure IC).
The total incorporation intoboth DX-treated andcontrols was lower
by an order of magnitude, and P1 and P2 were reduced five- to
tenfold by DX treatment (Figure IC). The only effect ofremoval of
serum was the disappearance ofP2 (data not shown).
Medium frompost-confluent (lateplateauphase) cells
Cells labelled after exposure to DX after 8 days in plateau showed
a further twofold reduction in incorporation and inhibition of P1
by DX (Figure Id). No induction ofP3a was seen. There was small
but significant incorporation into the region corresponding to
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Figure 1 Elution profile, from DEAE-Memsep, of unlabelled GAGs (Sigma) and 3H-labelled material in medium from A549 cells. 3H-labelled medium was
produced as described in the Methods, desalted and the constituents separated by anion exchange chromatography, and aliquots of each fraction counted on a
scintillation counter. Activity is expressed as d.p.m. 10-3 cells. (A) and 0, elution profile of unlabelled GAGs (Sigma), estimated by absorbance in the
carbazole reaction (see Materials and methods); ..... salt gradient. (B) Elution profile from subconfluent cells. 0, Without DX pretreatment; *, after 3 days'
pretreatment with 0.25 gM DX. (C) As B but with confluent cells. (D) As (B) but with cells 8 days post confluence. HA, hyaluronic acid; HS, heparan sulphate;
CS, chondroitin sulphate
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Figure 3 Induction of alkaline phosphatase by combination of CM with HS
fractions. HS1 and HS2 were purified from the medium and trypsinate of DX-
treated A549 cells, combined with CM, and used to treat A549 cells for 48 h,
afterwhich AP activity was assayed. SF, serum-free control; DX, 0.25 gM
dexamethasone; CM, medium conditioned by post-confluent fibroblasts; HS1t
and HS2t, HS1 and HS2 from A549 cell trypsinate; HS1 m and HS2m, HS1
and HS2 from A549-conditioned medium. Error bars are standard error of the
mean (+ s.e.m.)
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Figure 2 Elution profile, from DEAE-Memsep, of 3H-labelled material in
trypsinate from A549 cells. 3H-labelled trypsinate was prepared as
described in Materials and methods, and chromatography, elution and
counting carried out as in Figure 1. Activity is quoted as d.p.m. 10-9; cells, as
the activity in the trypsinate was lower than that in the medium. 0, Data from
DX-pretreated cells. (A) subconfluent cells, (B) confluent cells, (C) 8 day
post-confluent cells
chondroitin sulphate in both confluent and post-confluent cells,
and this was reduced by DX.
Trypsinate from subconfluent cells
[3H]GLN incorporation was stimulated in the heparan sulphate
region, with a small increase (approximately 2.5-fold) in P3a and a
larger increase (approximately fivefold) in P3b (Figure 2A). P1
was induced about 50% and P2 (HA) was not seen. Incorporation
in the region ofchondroitin sulphate (P4) was inhibited by DX.
Trypsinate from confluent (earlyplateauphase) cells
Incorporation increased overall, relative to subconfluent cells, and
was greatest in P1 but inhibited by DX. Some incorporation was
seen in the HA region (P2), but was again suppressed by DX. A
small P3a peak was seen with little effect of DX. The small
amount ofincorporation in P4 was reduced by DX (Figure 2B).
Trypsinate from post-confluent (lateplateauphase) cells
Incorporation was reduced throughout. Although a small P3a peak
was seen, stimulation by DX was not consistently observed. The
activity of DX was mainly inhibitory, particularly in P1 and P4
(Figure 2C).
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Figure 4 Effect of DX treatment of A549 cells during conditioning of medium.
HS1 and HS2 were prepared from A549-conditioned medium as described in
Materials and methods and used in combination with CM from fibroblasts to
induce AR [-, HS1 and HS2 from untreated A549 cells; *, HS1 and HS2
from A549 cells pretreated with 0.25gM DX. CM+HS1,2: HS1,2 combined
with fibroblast-conditioned medium; SF+HS1,2: HS1,2 combined with serum-
free medium control. Error bars are + s.e.m.
Effect of eluate fractions in DX stimulation of AP
activity
Fractions from medium and trypsinate from DX-treated subcon-
fluent A549 cells, corresponding to P3a, usually pooled fractions
23 and 24 (designated HS1), and P3b, usually fractions 26, 27 and
28 (designated HS2), were collected, desalted, diluted in
F1O:DMEM and mixed 1:1 with CM. They were then added at a
final HS concentration of 7.2 jg ml-' (determined by carbazole
estimation) to microtitration plate cultures under standard AP
induction conditions (see Materials and methods). No effect was
seen with HS1 (P = 0.68 vs CM), and a 30% induction with HS2
(P < 0.001) from cell trypsinate. However, HS1 from the medium
(CM + HS1m) showed a 17-fold induction (P < 1 x 10-8), 40%
more than CM + DX (12-fold) (P < 1 x 105) (Figure 3). HS1
showed no inductive activity without CM (Figure 4: SF+HS1), but
HS2 showed twofold induction alone (SF+HS2; P< 1 x 105). HS1
from A549 cells that had not been exposed to DX showed similar
activity with or without CM (Figure 4, open bars), and HS2 was
unaffected by pretreatment of the A549 cells. Pretreatment of
A549 cells with DX was essential for the positive interaction of
HS1 with CM (Figure 4: CM+HS1, solidbar). CM alone gave 70%
induction (P < 1 x 104) and HS1 from untreated A549 inhibited
0.01
JIA I I I I I, . . . . . . ,l
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. I . . 1.
. ..I
0.1 1 10
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Figure 5 Dose-response curve of HS1 in the presence of CM. AP was
induced as described in Materials and methods using CM combined with
different concentrations of HS1 from the medium of DX-treated A549 cells.
HS1 concentration was determined by the carbazole reaction (Bitter and Muir,
1962). Error bars are ± s.e.m.
this by 20% (P = 0.005). When DX was added to CM + HS1 from
DX-treated A549 cells, during induction of AP, there was no
furtherincrease in APactivity and, in fact, AP wasreducedby 10%
(P = 0.04) (data not shown). Dose-response curves ofHS1 showed
optimal activity at around 5 gg ml-' (Figure 5).
Effect of GAG-degrading enzymes
Heparinase reduced the activity ofHS1 by 94% after 8 h (P < 1 x
106) and 99.5% after 31 h (P < 10-) (Figure 6A). Heparitinase
reduced the activity ofHS1 by 97% (P < 1 x 10-10). Radioactivity
in peak P3a, rechromatographed after enzymatic digestion, was
reduced 81% by heparinase and 88% by heparitinase (data not
shown). Chondroitinase ABC had no significant effect on the
activity of HS1 (P = 0.4) (Figure 6B) and only reduced
rechromatographed P3a by 2% (data not shown).
Effect of HS1 on activity of cytokines
IL-6 and OSM, previously shown to be active in the induction of
AP in A549 cells (McCormick et al, 1995; McCormick and
Freshney, 1996), with optimal activity at 2.5 ,ug ml-' and 10 ng ml-'
respectively, were used to induce AP in A549 cells, in the presence
and absence of DX or HS1. While OSM at 10 ng ml-' induced AP
fivefoldinthe presenceof0.25gM DX (P< 1 x 10-5), itinduced AP
more than sevenfold in the presence of5.0jg ml-' HS1 (P<lx 10--
vs OSM alone; P =0.0013 vs OSM + DX). Similarly, while IL-6 at
2.5 jg ml-' induced AP threefold in the presence of 0.25 jM DX
(P <-0.005), it induced AP nearly sevenfold in 5.0 jg ml-' HS1
(P <1 x 10-5 vs IL-6 alone; P <0.0005 vs IL-6 + DX) (Figure 7).
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Figure 6 Effect of digestion by heparin lyases on HS1 activity. HS1 was purified as before, adjusted to 5.0 9g ml-', and treated for 8 h or 31 h with heparinase
or heparitinase as described in Materials and methods. Lyase activity was terminated by boiling and the products used in AP induction in the presence of
fibroblast CM as described above. HS1 (Hp8), HS1 treated with heparinase for 8 h; HS1 (Hp3l), HS1 treated with heparinase for 31 h; HS1 (B), untreated HS1,
boiled control; HS1 (Ht), HS1 treated with hepartinase for 31 h; HS1 (C), HS1 treated with chondroitinase ABC for 31 h. Error bars are +s.e.m.
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Figure 7 Induction of alkaline phosphatase by OSM and IL-6 in combination
with HS1. HS1, 5.0 jig ml-', was prepared from the medium of DX-treated
A549 cells and combined with CM, OSM 10 ng ml-' or IL-6 2.5 gg ml-', and
AP activity assayed 3 days later. Abbreviations as in previous figures and as
in text. Error bars are +s.e.m.
DISCUSSION
The activity of many growth factors, such as FGF-2 and TGF-,, is
regulated by their binding to soluble and membrane-bound low-
affinity receptors (Ruoslahti et al, 1992; Lopez-Casillas et al,
1993; de Wynter et al, 1993; Piepkorn et al, 1994; Strain et al,
1994; Walker et al, 1994), many of which are proteoglycans. The
role of these receptors is not entirely clear, but they may be
involved in sequestration and/or stabilization (McCaffrey et al,
1994), or translocation of the growth factor to the high-affinity
receptor (Klagsbrun and Baird, 1991; Ruoslahti et al, 1992). As
DX was shown to enhance the activity of growth factors involved
in A549 differentiation (although not the activity of FGF-2)
(McCormick et al, 1995), and preliminary data suggested that the
effect was stable after removal ofDX, this suggested that a matrix
constituent might be involved, particularly as previous work
(McLean, 1986; Mackie et al, 1988) had shown that DX influences
the secretion ofGAGs by glioma cell lines and by A549.
DX was shown to have a profound effect on secreted and
membrane-associated GAGs in A549 cells. Incorporation of
[3H]GLN was stimulated in three peaks ofactivity eluting at 0.1 M,
0.25 M and 0.35 M sodium chloride in subconfluent cells. P1 did
not correspond to any of the unlabelled GAGs, and although the
increase in P2 corresponded to hyaluronic acid characterization of
this peak has not yet been carried out. Although both P1 and P2
were induced by DX in subconfluent cells, they were inhibited by
DX in confluent and post-confluent cells. The significance of this
reversal is not clear but may be associated with the shift from the
high growth fraction associated with subconfluent cultures to the
low growth fraction found in confluent cultures.
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The 0.35 M sodium chloride peak, designated P3a, corresponded
to a low-salt-eluting fraction of heparan sulphate. As previous
reports have implicated the heparan sulphate group of proteogly-
cans in growth factor binding (Klagsbrun and Baird, 1993; de
Wynter et al, 1993), this peak was selected for further study. The
induction ofthis peak was seen in both the medium and the trypsi-
nate of subconfluent cells, but not in confluent and post-confluent
cultures. Induction in the medium was much greater than that in
the trypsinate, in which induction of P3b (0.4 M sodium chloride
eluate) was found to be greater. When material from the medium
and trypsinate of subconfluent cultures was isolated (designated
HS1 from the highest radioactivity fraction in P3a, and HS2 from
the middle ofP3b) and used instead ofDX in the induction ofalka-
line phosphatase in A549 cells by CM, only HS1 from the medium
was found tobe active (Figure 3). Cell-associated (trypsinate) HS1
was inactive, and both cell-associated and soluble HS2 were
unable to replace DX, although HS2 from the trypsinate and the
medium gave 30% and 40% induction with CM, minor effects
compared with HS1 from the medium. HS1 from the medium had
no inductive activity alone. HS2 from the medium induced AP
twofold, in the absence of CM, whether from DX-treated or
untreated A549 cells. However, as these effects were slight
compared with the effect of HS1 from A549 medium, they were
not investigated further.
HS1 was also active in replacing DX in the induction of AP by
OSM and IL-6, with HS1 giving a higher response to cytokine
than DX in both cases.
Although HS1 isolated from medium and trypsinate was used in
the AP assay at the same concentration in control cells, i.e. without
DX pretreatment, pooling the d.p.m. per 106 cells from fractions
20-25 showed that about four times as much [3H]GLN incorpora-
tion appeared in the medium as in the trypsinate (Table 2). After
DX treatment, incorporation in the medium increased 37-fold,
whereas that in the trypsinate only increased 2.4-fold, giving a
new ratio of medium to trypsinate of 65-fold. As HSI from the
medium was by far the most active, HS1 from the trypsinate,
which only increased 2.4-fold with DX as opposed to 37-fold in
the medium, was not analysed further.
It is not clear why this activity is not cell associated, as one
might expect ifitperformed the role ofa low-affinity translocating
receptor, but it may be due to the transformed nature of the A549
cells, where surface proteolysis may release membrane-bound
proteoglycans into the medium. Skinner et al (1987) found the
ratio of proteoglycans between medium and the cell layer to be
similar in rat type II cells in culture, but found that both fractions
were reduced with cortisol. Whether this difference is due to
species, developmental stage or transformation is not clear.
Prior incubation ofHS1 with heparinase orheparitinase, both of
which cleave heparan sulphate, destroyed its activity, but incuba-
tion with chondroitinase ABC, which is inactive against heparan
sulphate but degrades chondroitin sulphate and hyaluronic acid,
had no effect. As heparitinase acts specifically on heparan sulphate
(Jandik et al, 1994), this suggests that the active material is a
species ofheparan sulphate. As the purified material was protease
treated before fractionation, and only minimal absorbance at
280 nm was observed around the active fractions, suggesting that
little residual protein remained, the activity may lie in the carbohy-
drate moiety. However, the presence and activity ofsmall residual
peptide chains cannot be totally excluded.
It is surprising that IL-6 synthesis has been shown to be down-
regulated by DX in lung fibroblasts (McCormick et al, 1995),
whereas HS1 is stimulated in the target cells that respond to IL-6.
However, IL-6 may not be the main paracrine factor from fibro-
blasts responsible forA549 cell and type II cell differentiation, and
the main candidate, FPF, which has been shown to be up-regulated
in perinatal lung fibroblasts by cortisol (Post and Smith, 1984),
still remains to be identified.
Although many growth factors are dependent on binding to HS
for activation, there is no record ofthis for IL-6 or OSM, although
Han et al (1996) observed potentiation of IL-6 by heparin and HS
in haematopoietic cells. This may be a new species of HS that
interacts with the IL-6 group of cytokines, as we have previously
(McCormick and Freshney, 1996) seen DX-dependent activity in
LIF as well as OSM and other members of the IL-6 group.
However, DX is also required for the inductive action of insulin
and IFN-3 in this system (McCormick et al, 1995), and it would be
surprising to find a common reactive species of HS for such a
disparate group. It is possible that each of these agents is capable
of inducing the production of an autocrine factor by A549 cells
(Stadnyk, 1994). This autocrine factor may be HS dependent and
activated by HS1. The current data suggest that untreated A549
cells do not make this autocrine factor constitutively as HS1 is not
active alone.
ABBREVIATIONS
AP, alkaline phosphatase; CM, fibroblast-conditioned medium;
DMEM, Dulbecco's modification of Eagle's medium; DX, dexa-
methasone; FIO:DMEM, 50:50 mixture of Ham's FIO and
DMEM; FPF, fibrocyte-pneumocyte factor; GAG, glycosamino-
glycan; GLN, glucosamine; HA, hyaluronic acid; HS, heparan
sulphate; IL-6, interleukin 6; LIF, leukaemia inhibitory factor;
OSM, oncostatin M; PNP, p-nitrophenol; PS, pulmonary surfac-
tant; SF, serum-free FIO:DMEM medium.
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